(113 days)
Not Found
Yes
The document explicitly states that the device utilizes machine learning technologies.
No.
The device is a software tool designed to aid in measurements from existing radiographs, not to directly treat or prevent a disease or condition. Its purpose is to assist in diagnosis, not to provide therapy.
No
The device is intended to aid dental professionals in the measurement of bone levels, and explicitly states it "should not be used in-lieu of full patient evaluation or solely relied on to make or confirm a diagnosis." It is not intended to diagnose.
Yes
The device description explicitly states that Adravision Perio is a "Software as a Medical Device (SaMD)". The summary focuses entirely on the software's function, performance, and validation using existing radiographic images, with no mention of accompanying hardware components required for its operation beyond the input images themselves.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: Adravision Perio is a software device that processes radiological images (bitewing and periapical radiographs) to measure bone levels. It does not analyze biological samples from the patient's body.
- Intended Use: The intended use is to aid dental professionals in measuring bone levels from images, not to perform a diagnostic test on a biological specimen.
The device falls under the category of medical image processing software, specifically for dental radiology.
No
The letter does not explicitly state that the FDA has reviewed and approved or cleared a PCCP for this specific device.
Intended Use / Indications for Use
Adravision Perio is a radiological semi-automated image processing software device intended to aid dental professionals in the measurements of mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs. It should not be used in-lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. The intended users of Adravision Perio are trained professionals including, but not limited to, dental hygienists. The intended patient population of the device is patients living in the United States, who are 22 years old or older, and that do not have any remaining primary teeth. Adra Corporation has not evaluated the performance of the device on primary dentition.
Product codes
QIH
Device Description
Adravision Perio is a Software as a Medical Device (SaMD intended to aid dentists in the measurement of mesial and dista bone levels associated with each tooth on bitewing and periapical dental radiographs of permanent teeth in patients 22 years of age or older.
The device provides assistance to dentists by suggesting the measurement of interproximal bone levels. The device recommendations are for reference only and the user should review associated radiographs, view annotations and modify annotations if needed. The device is not intended as a replacement for a complete clinician's review or their clinical judgment because users can take into account other relevant information from the image, intraoral exam or patient history.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Both the proposed and the predicate device are designed to be similar in intended use, indications for use, intended users, and intended use environment. Both devices utilize machine learning technologies to measure interproximal bone levels in dental radiographs and allow users to visualize the radiographs with annotations, add their own annotations and use the information as part of their diagnostic decision.
Input Imaging Modality
bitewing and periapical radiographs
Anatomical Site
Teeth (mesial and distal bone levels associated with each tooth)
Indicated Patient Age Range
patients living in the United States, who are 22 years old or older, and that do not have any remaining primary teeth.
Intended User / Care Setting
trained professionals including, but not limited to, dental hygienists.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
In the OKS Assessment. Adravision Perio was evaluated with a total dataset of 340 dental radiographs (bitewing and periapical radiographs) and evaluated the precision and recall against the key points labeled by a ground truther within those radiographs.
In the Length Measurement Assessment, Adravision Perio was evaluated with a dataset of 78 dental radiographs and evaluated the sensitivity and specificity against the consensus CAL length measurements labeled by three (3) ground truthers within those radiographs.
No adverse effects or complications were recorded associated with this bench study since all radiographs were collected retrospectively and no treatment decisions were made.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench Testing
Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use. Bench testing included evaluation of performance based upon a ground truth data set utilizing (i) Object Key Similarity (OKS) Assessment, and (ii) Length Measurement Assessment.
Object Key Similarity (OKS) Assessment
- Sample Size: 340 dental radiographs (bitewing and periapical radiographs).
- Key Results:
- Precision (Bitewing): 91.0%
- Recall (Bitewing): 94.0%
- Precision (Periapical): 84.8%
- Recall (Periapical): 89.3%
- Overall tooth number classification accuracy: 91.8%
Length Measurement Assessment
- Sample Size: 78 dental radiographs.
- Key Results:
- Sensitivity (Bitewing): 90.7 %
- Specificity (Bitewing): 94.3 %
- Mean Absolute Error (Bitewing): 0.434 mm
- Sensitivity (Periapical): 92.5 %
- Specificity (Periapical): 86.8 %
- Mean Absolute Error (Periapical): 0.504 mm
- Overall tooth number classification accuracy: 93.2%
Subgroup Analysis: Analysis of study results for patient age, gender, clinic site, region of the mouth and sensor type were performed as subgroup analysis.
Conclusion: Our bench testing showed that Adravision Perio software met the prespecified performance requirements when evaluated against ground truth labeling and demonstrated robustness and reliability in drawing CAL line segments in clinically relevant locations with accurate length on the relevant tooth.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Object Key Similarity (OKS) Assessment:
- Precision (Bitewing): 91.0%
- Recall (Bitewing): 94.0%
- Precision (Periapical): 84.8%
- Recall (Periapical): 89.3%
Length Measurement Assessment:
- Sensitivity (Bitewing): 90.7 %
- Specificity (Bitewing): 94.3 %
- Mean Absolute Error (Bitewing): 0.434 mm
- Sensitivity (Periapical): 92.5 %
- Specificity (Periapical): 86.8 %
- Mean Absolute Error (Periapical): 0.504 mm
Overall Metrics:
- Overall tooth number classification accuracy (OKS study): 91.8%
- Overall tooth number classification accuracy (Length Assessment): 93.2%
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
December 5, 2023
Adra Corporation % Moeini Golnaz Regulatory Consultant GM Consulting 1425 Golden Meadow Square SAN JOSE, CA 95117
Re: K232440
Trade/Device Name: Adravision Perio Regulation Number: 21 CFR 892.2050 Regulation Name: Medical image management and processing system Regulatory Class: Class II Product Code: QIH Dated: November 9, 2023 Received: November 9, 2023
Dear Moeini Golnaz:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerelv.
Lu Jiang
Lu Jiang, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiologic Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Indications for Use
510(k) Number (if known) K232440
Device Name Adravision Perio
Indications for Use (Describe)
Adravision Perio is a radiological semi-automated image processing software device intended to aid dental professionals in the measurements of mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs. It should not be used in-lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. The intended users of Adravision Perio are trained professionals including, but not limited to, dental hygienists.
The intended patient population of the device is patients living in the United States, who are 22 years old or older, and that do not have any remaining primary teeth. Adra Corporation has not evaluated the performance of the device on primary dentition.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for "adravision". The logo consists of a stylized, abstract symbol to the left of the word "adravision". The symbol is a teal-colored, curved shape that resembles a stylized letter "C" or a crescent moon. The word "adravision" is written in a sans-serif font, with all letters in lowercase.
510(k) Summary (K232440)
This summary of 510(k) information is being submitted in accordance with the requirements of 21 CFR Part 807.92.
| Date: | Dec 1, 2023 |
|---|---|
| Applicant: | MedEdge Consulting |
| Golnaz Moeini | |
| golnaz.moeini@gmail.com | |
| 408-504-3187 |
| Trade Name: | Adravision Perio |
|---|---|
| Common Name: | Dental Image Processing Software |
| Regulation Name: | Medical Image Management and Processing System |
| Regulation Number: | 21 CFR 892.2050 |
| Product Code: Device | QIH |
| Classification: Device | Class II |
| Description: | Adravision Perio is a Software as a Medical Device (SaMD intended to aid dentists in the measurement of mesial and dista bone levels associated with each tooth on bitewing and periapical dental radiographs of permanent teeth in patients 22 years of age or older. |
The device provides assistance to dentists by suggesting the measurement of interproximal bone levels. The device recommendations are for reference only and the user should |
device should review associated radiographs, view annotations and modify annotations if needed. The device is not intended as a replacement for a complete clinician's review or their clinical judgment because users can take into account other relevant information from the image, intraoral exam or patient history.
4
Image /page/4/Picture/0 description: The image shows the logo for Adravision. The logo consists of a stylized, abstract symbol to the left of the word "adravision". The symbol is a teal-colored, curved shape that resembles a stylized letter "C" or a crescent moon. The word "adravision" is written in a simple, sans-serif font and is colored black.
| Indications for Use: | Adravision Perio is a radiological semi-automated image
processing software device intended to aid dental professionals
in the measurements of mesial and distal bone levels associated
with each tooth from bitewing and periapical radiographs. It
should not be used in-lieu of full patient evaluation or solely
relied upon to make or confirm a diagnosis.
The intended users of Adravision Perio are trained professionals
including, but not limited to, dentists and dental hygienists.
The intended patient population of the device is patients living
in the United States, who are 22 years old or older, and that do
not have any remaining primary teeth. Adra Corporation has not
evaluated the performance of the device on primary dentition. |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Predicate Device: | Overjet Inc., Overjet Dental Assist, 510(k): K210187
Trade Name: Overjet Dental Assisst
Classification Name: Medical Image Management and Processing System
Regulation number: 21 CFR 892.2050, Product Code: LLZ, Class II |
Substantial Equivalence:
| Feature/
Function | Proposed Device
Adravision Perio Device | Primary Predicate
Overjet Dental Assist
K210187 | Identical? |
|-------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------|------------|
| Data source | Bitewing and periapical
radiographs | Bitewing and periapical
radiographs | Yes |
| Image input
sources1 | Images imported from the
radiographic device, or
from the practice
management system, or
manually uploaded into the
system | Images imported from the
radiographic device, or from
the practice management
system | No |
| Image
format2 | DICOM, JPEG, JPG, PNG,
TIFF, TIF, JFIF or BMP
file | jpg, png, jfif, eop, etp, jif | No |
| Platform3 | Web- Edge, Chrome,
Firefox, Brave, Safari | Web - Edge, Chrome, Firefox | No |
| End user | Dentist, dental hygienist | Dentist, dental hygienist | Yes |
| Patient
population | The intended patient
population of the device is | The intended patient
population of the device is | Yes |
5
Image /page/5/Picture/0 description: The image shows the logo for Adravision. The logo consists of a stylized, abstract shape in a light blue color, resembling a crescent or a curved ribbon. To the right of the shape is the word "adravision" in a sans-serif font, with the letters in black.
| Feature/
Function | Proposed Device
Adravision Perio Device | Primary Predicate
Overjet Dental Assist
K210187 | Identical? |
|--------------------------------------|--------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|------------|
| | patients living in the United
States, who are 22 years old
or older, that do not have
any remaining primary
teeth. | patients living in the United
States, who are 22 years old
or older, and that do not have
any remaining primary teeth. | |
| Operating
system | Any | Any | Yes |
| User
Interface | Mouse, keyboard, trackpad | Mouse, keyboard, trackpad | Yes |
| Patient
Database
Compatibility | SQL | SQL | Yes |
| Image
Viewing | Full, thumbnail | Full, thumbnail | Yes |
| Features
detected | Bone level | Bone level | Yes |
| Model output | Line segments | Line segments | Yes |
Discussion of Differences
Both the proposed and the predicate device are designed to be similar in intended use, indications for use, intended users, and intended use environment. Both devices utilize machine learning technologies to measure interproximal bone levels in dental radiographs and allow users to visualize the radiographs with annotations, add their own annotations and use the information as part of their diagnostic decision.
Other similarities include both software have no direct contact with the patient and both systems utilize standard image types.
A few technological differences between the proposed and the predicate device are discussed below. These differences are deemed to not raise questions of safety and efficacy are detailed below.
Image input sources- - Both the proposed device and predicate support image input sources from the radiographic device and the practice management system. The proposed device
6
Image /page/6/Picture/0 description: The image shows the logo for Adravision. The logo consists of a stylized, teal-colored graphic to the left of the word "adravision" in a sans-serif font. The graphic resembles a crescent shape formed by two curved lines.
additionally accepts manual upload of radiographs into the software which the predicate device does not support. The V&V testing for the device demonstrates the device's capability in supporting the analysis of all image input sources. This minor difference does not raise new questions of safety and efficacy compared to the predicate device.
Image formats2 - Both the proposed device and predicate support image formats of JPG, PNG, and JFIF. The proposed device additionally accepts DICOM. JPEG, TIFF, TIF and BMP image formats that the predicate device does not support. The V&V testing for the device demonstrates the device's capability in supporting the analysis of all the designated image formats and demonstrates that this minor difference does not raise new questions of safety and efficacy compared to the predicate device.
Platform2 - Both the proposed device and predicate device support common browsers of Edge, Chrome and Firefox. The proposed device additionally works on Safari and Brave. The V&V testing for the device demonstrates the device's capability to function on designated browsers and demonstrates that this minor difference does not raise new questions of safety and efficacy compared to the predicate device.
Performance Testing:
Software Verification and Validation Testing
Software verification and validation testing were conducted and documentation provided as recommended by FDA's Guidance for Industry and FDA Staff. "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". The software for this device was considered as a Basic Documentation Level, since a failure or latent flaw could indirectly result in minor injury to the patient or user through incorrect or delayed information through the action of a care provider.
Bench Testing
Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use.
Bench testing included evaluation of performance based upon a ground truth data set utilizing (i) Object Key Similarity (OKS) Assessment, and
(ii) Length Measurement Assessment.
In the OKS Assessment. Adravision Perio was evaluated with a total dataset of 340 dental radiographs (bitewing and periapical radiographs) and evaluated the precision and recall against the key points labeled by a ground truther within those radiographs.
7
Image /page/7/Picture/0 description: The image shows the logo for "adravision". The logo consists of a stylized, abstract symbol to the left of the word "adravision". The symbol is a teal-colored, curved shape that resembles a stylized eye or a crescent moon. The word "adravision" is written in a simple, sans-serif font in black.
| Metric | Bitewing | Periapical |
|---|---|---|
| Precision | 91.0% | 84.8% |
| Recall | 94.0% | 89.3% |
In the Length Measurement Assessment, Adravision Perio was evaluated with a dataset of 78 dental radiographs and evaluated the sensitivity and specificity against the consensus CAL length measurements labeled by three (3) ground truthers within those radiographs.
| Metric | Bitewing | Periapical |
|---|---|---|
| Sensitivity | 90.7 % | 92.5 % |
| Specificity | 94.3 % | 86.8 % |
| Mean Absolute Error | 0.434 mm | 0.504 mm |
Analysis of study results for patient age, gender, clinic site, region of the mouth and sensor type were performed as subgroup analysis.
Adravision Perio also obtained an overall tooth number classification accuracy of 91.8% in the OKS study and 93.2% in the Length Assessment demonstrating that it can well locate the CAL measurements on the relevant tooth number and tooth surface.
Our bench testing showed that Adravision Perio software met the prespecified performance requirements when evaluated against ground truth labeling and demonstrated robustness and reliability in drawing CAL line segments in clinically relevant locations with accurate length on the relevant tooth.
No adverse effects or complications were recorded associated with this bench study since all radiographs were collected retrospectively and no treatment decisions were made.
Conclusion:
Adravision Perio is substantially equivalent to the predicate device, Overjet Dental Assist. Differences do not raise any concerns about the safety or efficacy of the device.